Stockreport

Eli Lilly's new GLP-1 pill vs. Wegovy, JPMorgan initiates coverage on Hims [Yahoo! Finance Canada]

Novo Nordisk A/S  (NVO) 
Last novo nordisk a/s earnings: 2/5 01:31 am Check Earnings Report
US:NYSE Investor Relations: novonordisk.com/investors.html
PDF prescriptions for Eli Lilly's ( ) new GLP-1 weight-loss drug reportedly trailing the oral version of Novo Nordisk's Wegovy ( ), JPMorgan analysts initiating coverage on [Read more]